Our Science Desk
Hyderabad: In a potentially significant breakthrough in the quest to treat paralysis caused by spinal cord injuries, scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, have identified two genes capable of restoring the ability of damaged nerve fibres to regenerate in adult mice.
The discovery offers fresh hope for developing future therapies for spinal cord injuries, which often result in permanent paralysis because damaged nerve fibres in the adult mammalian central nervous system have very limited capacity to regrow.
The research team, led by Dr Ishwariya Venkatesh, identified two developmental genes, NR2F1 and NR2F6, which appear to play a crucial role in switching the nerve regeneration programme back on. Activating either gene resulted in nerve fibres growing across the injury site in mice, accompanied by measurable improvements in movement and limb function.
The findings challenge a long-standing scientific understanding that mature neurons lose their ability to regenerate as the brain develops. Instead, the researchers suggest that the genetic instructions for nerve growth remain intact but become progressively silenced with age.
Unlocking a dormant regeneration programme
The ability to regenerate damaged nerves is not entirely absent in nature. Zebrafish, for instance, can regrow nerve fibres in their brain and spinal cord following injury. Even humans retain the ability to regenerate peripheral nerves in their arms and legs. During embryonic development, neurons also readily extend long nerve fibres.
However, this regenerative capacity diminishes considerably as mammalian neurons mature.
To understand why, the CCMB team investigated the developing mouse brain, looking for proteins that bind to growth-related genes in young animals but disengage from them as the brain matures. Their search identified NR2F1 and NR2F6, neither of which had previously been associated with nerve regeneration in the brain or spinal cord.
The researchers found that levels of both genes decline by approximately 70 to 80 per cent in the adult brain. Restoring their activity in adult mice triggered substantial nerve fibre regrowth following spinal cord injury, with fibres extending up to 1.5 millimetres beyond the injury site. In contrast, untreated animals showed severely stunted nerve growth, with fibres largely stopping at the injury-associated scar.
More significantly, the treated mice demonstrated functional improvements. They could lift their hind limbs while walking, push backwards and showed improved grip strength. These gains became apparent around five weeks after injury and persisted during the observation period.
Two genes, two different strategies
An intriguing aspect of the discovery is that the two genes stimulate regeneration through almost opposite molecular mechanisms.
NR2F1 activates genes involved in reorganising DNA packaging and rebuilding the internal structural framework of neurons, effectively recreating cellular conditions favourable for growth.
NR2F6, meanwhile, follows a different strategy. It suppresses a broad range of genes, including those associated with routine protein production, while selectively preserving the activity of thousands of growth-related genes. This appears to redirect the neuron’s resources from routine maintenance towards rebuilding damaged nerve fibres.
The finding challenges the conventional assumption that nerve regeneration necessarily requires increased overall protein production. In this instance, selectively switching off certain genes appears to be as important as activating others.
The team also discovered that NR2F6 physically reorganises the three-dimensional structure of DNA within injured neurons, creating hundreds of new folded domains that bring growth-related genes closer to their regulatory switches. This is the first reported evidence of such three-dimensional genome reorganisation accompanying nerve regeneration in the brain or spinal cord.
“Adult neurons have not lost the programme for regrowth; it has been silenced as the brain matures,” said Dr Venkatesh. “What this work shows is that two different molecular routes can bring that programme back, and both lead to recovery.”
The discovery that two genes operating through contrasting mechanisms can produce comparable functional improvements opens up potentially wider avenues for designing gene-based therapies for spinal cord repair.
The study, led by first author Yogesh Sahu, has been published in The EMBO Journal.
A promising beginning, not yet a cure
Despite its promise, the breakthrough remains at the experimental stage. The researchers delivered the genes before inducing the spinal cord injury in mice, and the resulting recovery was partial rather than complete.
Much more research will be required to establish whether the approach can work when treatment is administered after an injury, whether it is safe and effective in larger animals, and whether the findings can eventually translate into human therapies.
Nevertheless, by demonstrating that the adult nervous system may retain a dormant capacity for regeneration, the CCMB research provides an important new direction in the global effort to tackle spinal cord injuries and paralysis.
